|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/407 | (2006.01) | ||
| C07D 519/00 | (2006.01) | ||
| A61P 7/00 | (2006.01) |
| (11) | Number of the document | 3483164 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18209919.2 |
| Date of filing the European patent application | 2018-03-20 | |
| (97) | Date of publication of the European application | 2019-05-15 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-04 |
| (46) | Date of publication of the claims translation | 2020-05-11 |
| (30) | Number | Date | Country code |
| 201762473751 P | 2017-03-20 | US |
| (72) |
ERICSSON, Anna, US
GREEN, Neal, US
GUSTAFSON, Gary, US
HAN, Bingsong, US
LANCIA JR., David, R, US
MITCHELL, Lorna, US
RICHARD, David, US
SHELEKHIN, Tatiana, US
SMITH, Chase C., US
WANG, Zhongguo, US
ZHENG, Xiaozhang, US
|
| (73) |
Novo Nordisk Health Care AG,
The Circle 32/38, 8058 Zürich,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirolpirolo kompozicijos kaip piruvato kinazės (PKR) aktyvatoriai |
| PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS |
| Payment date | Validity (years) | Amount | |
| 2026-02-19 | 9 | 208.00 EUR |
| 2027-03-20 |